High-risk neuroblastoma

The Impact of COG versus Rapid COJEC Chemotherapy on Survival Following Autograft for High-Risk Neuroblastoma: A Ten-Year Retrospective Study from a Tertiary Referral Centre from Southern India
Central Nervous System Recurrence (Isolated/Multi-site) in Patient With HR NBL: Incidence, Clinical feature and Outcome in the Post Immunotherapy Era Multi-Centre Study, National Guard Hospital Jeddah and Riyadh 2010-2023
Treatment Outcomes in High-Risk Neuroblastoma in Children Treated with Dinutuximab Beta: A 15-Year Retrospective Single-Center Study Experience
Local Control with 21 vs 36 Gy radiation Therapy of the Primary Tumor Bed for High-Risk Neuroblastoma